Who
Christopher Mirabelli
Director
Company insider
Files Form 4 as: Chairman of the Board, Cypherpunk Technologies; Other, Globeimmune; Director and 10% owner, Proteostasis Therapeutics; 10% owner, Radius Health; 10% owner, Activbiotics; 10% owner, Altimmune.
In numbers
- Trades disclosed
- 57
- Buys
- 4
- Sells
- 5
- Bought
- $9.4M
- Sold
- $2.2M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 3 Aug 2007
- Last trade
- 26 Mar 2026
- Last filed
- 30 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Mar 2026filed 30 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $43K60,000 at $0.7105 | filing |
| 26 Mar 2026filed 30 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $43K60,000 at $0.71 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —74,700 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —94,050 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —74,700 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —74,700 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —94,050 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —94,050 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —74,700 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —94,050 | filing |
| 23 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —94,050 at $0.00 | filing |
| 23 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code J | —2,136 at $0.00 | filing |
| 23 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code J | —712 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $822K261,840 at $3.14 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $1.3M414,479 at $3.14 | filing |
| 11 Nov 2025filed 13 Nov 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —74,700 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —22,500 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —22,500 | filing |
| 28 Mar 2025filed 1 Apr 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code F | $2,1356,672 at $0.32 | filing |
| 13 Nov 2024filed 15 Nov 2024 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code X | —2,136 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.